Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

Yan Li,1 Xiaomin Wang,2 Edward O’Mara,1 Meletios A Dimopoulos,3 Pieter Sonneveld,4 Katja C Weisel,5 Jeffrey Matous,6 David S Siegel,7 Jatin J Shah,8 Elisabeth Kueenburg,9 Lars Sternas,9 Chloe Cavanaugh,9 Mohamed Zaki,9 Maria Palmisano,1 Simon Zhou1 1Translational Development and C...

Full description

Bibliographic Details
Main Authors: Li Y, Wang X, O’Mara E, Dimopoulos MA, Sonneveld P, Weisel KC, Matous J, Siegel DS, Shah JJ, Kueenburg E, Sternas L, Cavanaugh C, Zaki M, Palmisano M, Zhou S
Format: Article
Language:English
Published: Dove Medical Press 2017-11-01
Series:Clinical Pharmacology : Advances and Applications
Subjects:
hemodialysis
pomalidomide
population pharmacokinetics
renal impairment
Online Access:https://www.dovepress.com/population-pharmacokinetics-of-pomalidomide-in-patients-with-relapsed--peer-reviewed-article-CPAA

Internet

https://www.dovepress.com/population-pharmacokinetics-of-pomalidomide-in-patients-with-relapsed--peer-reviewed-article-CPAA

Similar Items